Table 2. Patient characteristics and treatment histories.
| No. of patients | 29 |
| Median age: range (years) | 57 (38–78) |
| Performance status | |
| 0 | 8 (28%) |
| 1 | 17 (59%) |
| 2 | 1 (3%) |
| Unknown | 3 (10%) |
| Disease stage at diagnosis | |
| Ic | 1 (3%) |
| II | 1 (3%) |
| III | 17 (59%) |
| IV | 10 (34%) |
| Degree of differentiation at diagnosis | |
| Moderate | 7 (24%) |
| Poor | 22 (76%) |
| Prior chemotherapy: number of courses | |
| 1 | 4 (14%) |
| 2 | 13 (45%) |
| >2 | 12 (41%) |
| Treatment-free interval | |
| >6 months | 8 (28%) |
| <6 months | 21 (72%) |
| Prior platinum chemotherapy: best response | |
| Complete/partial response | 20 (70%) |
| Stable disease | 3 (10%) |
| Progressive disease | 0 |
| Not evaluable/unknown | 6 (21%) |
| Platinum-free interval | |
| >6 months | 20 (70%) |
| <6 months | 9 (30%) |
NB=no patients had received 5-FU previously.